Oravax Medical signed a cooperation and Purchase Agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Company to pre-purchase 10 million doses of Oravax’s oral COVID-19 vaccine…
…“This pre-purchase of our oral COVID-19 vaccine in development, represents a major milestone for Oravax Medical and another step forward in the implementation of our long-term strategy,” said Oramed CEO and Oravax Chairman Nadav Kidron.
Moreover, Tan Thanh Holdings has received approval from the Vietnamese Health Ministry to conduct advanced stage clinical trials of the vaccine to help advance it toward regulatory approval….
Source: Israel’s Oravax oral COVID-19 vaccine heads to Southeast Asia – The Jerusalem Post
Ned Hamson's Second Line View of the News 